1921
Volume 93, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract

Estimates of the risk of tuberculosis (TB) infection resulting from overseas deployment among U.S. military service members have varied widely, and have been plagued by methodological problems. The purpose of this study was to estimate the incidence of TB infection in the U.S. military resulting from deployment. Three populations were examined: 1) a unit of 2,228 soldiers redeploying from Iraq in 2008, 2) a cohort of 1,978 soldiers followed up over 5 years after basic training at Fort Jackson in 2009, and 3) 6,062 participants in the 2011–2012 National Health and Nutrition Examination Survey (NHANES). The risk of TB infection in the deployed population was low—0.6% (95% confidence interval [CI]: 0.1–2.3%)—and was similar to the non-deployed population. The prevalence of latent TB infection (LTBI) in the U.S. population was not significantly different among deployed and non-deployed veterans and those with no military service. The limitations of these retrospective studies highlight the challenge in obtaining valid estimates of risk using retrospective data and the need for a more definitive study. Similar to civilian long-term travelers, risks for TB infection during deployment are focal in nature, and testing should be targeted to only those at increased risk.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.15-0539
2015-12-09
2017-11-18
Loading full text...

Full text loading...

/deliver/fulltext/14761645/93/6/1172.html?itemId=/content/journals/10.4269/ajtmh.15-0539&mimeType=html&fmt=ahah

References

  1. Mancuso JD, Aaron CL, , 2013. Tuberculosis trends in the U.S. Armed Forces, active component, 1998–2012. MSMR 20: 48.
  2. Office of the Under Secretary for Personnel and Readiness, 2010. Department of Defense Instruction NUMBER 6130.03: Medical Standards for Appointment, Enlistment, or Induction in the Military Services. Washington, DC: Department of Defense.
  3. Mancuso JD, Tribble D, Mazurek GH, Li Y, Olsen C, Aronson NE, Geiter L, Goodwin D, Keep LW, , 2011. Impact of targeted testing for latent tuberculosis infection using commercially available diagnostics. Clin Infect Dis 53: 234244.[Crossref]
  4. Houk VH, Kent DC, Baker JH, Sorensen K, Hanzel GD, , 1968. The Byrd study. In-depth analysis of a micro-outbreak of tuberculosis in a closed environment. Arch Environ Health 16: 46.[Crossref]
  5. Lamar JE, 2nd Malakooti MA, , 2003. Tuberculosis outbreak investigation of a U.S. Navy amphibious ship crew and the Marine expeditionary unit aboard, 1998. Mil Med 168: 523527.
  6. Mancuso JD, Tobler SK, Eick AA, Keep LW, , 2010. Active tuberculosis and recent overseas deployment in the U.S. military. Am J Prev Med 39: 157163.[Crossref]
  7. Cobelens FG, van Deutekom H, Draayer-Jansen IW, Schepp-Beelen AC, van Gerven PJ, van Kessel RP, Mensen ME, , 2000. Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity. Lancet 356: 461465.[Crossref]
  8. Freeman RJ, Mancuso JD, Riddle MS, Keep LW, , 2010. Systematic review and meta-analysis of TST conversion risk in deployed military and long-term civilian travelers. J Travel Med 17: 233242.[Crossref]
  9. Mancuso JD, Tobler SK, Keep LW, , 2008. Pseudoepidemics of tuberculin skin test conversions in the U.S. Army after recent deployments. Am J Respir Crit Care Med 177: 12851289.[Crossref]
  10. Office of the Surgeon General, 2003. The Army Latent Tuberculosis Infection (LTBI) Surveillance and Control Program. Falls Church, VA: Department of the Army.
  11. Office of the Surgeon General, 2008. Supplemental Guidance for the Army Latent Tuberculosis Infection (LTBI) Surveillance and Control Program. Falls Church, VA: Department of the Army.
  12. Mancuso JD, Mazurek GH, Tribble D, Olsen C, Aroson NE, Geiter L, Goodwin D, Keep LW, , 2012. Discordance among commercially available diagnostics for latent tuberculosis infection. Am J Respir Crit Care Med 185: 427434.[Crossref]
  13. Bennett DE, Courval JM, Onorato I, Agerton T, Gibson JD, Lambert L, Mcquillan GM, Lewis B, Navin TR, Castro KG, , 2008. Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999–2000. Am J Respir Crit Care Med 177: 348355.[Crossref]
  14. Diagnostic Standards and Classification of Tuberculosis in Adults and Children, 2000. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999. Am J Respir Crit Care Med 161: 13761395.[Crossref]
  15. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K, , 2010. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection—United States, 2010. MMWR Recomm Rep 59 (RR-5): 125.
  16. Jung P, Banks RH, , 2008. Tuberculosis risk in US Peace Corps Volunteers, 1996 to 2005. J Travel Med 15: 8794.[Crossref]
  17. Kortepeter MG, Krauss MR, , 2001. Tuberculosis infection after humanitarian assistance, Guantanamo Bay, 1995. Mil Med 166: 116120.
  18. Emmons EE, Ljaamo SK, , 1999. Active tuberculosis in a deployed field hospital. Mil Med 164: 289292.
  19. Aaron CL, Mancuso JD, , 2014. Development and implementation of a cohort review for latent tuberculosis infection. MSMR 21: 27.
  20. Long E, , 1955. Tuberculosis in the Army of the United States in World War II; An Epidemiological Study with an Evaluation of X-ray Screening. Washington, DC: U.S. Government Printing Office.
  21. Centers for Disease Control and Prevention, 2006. Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC. Endorsed by the Advisory Council for the Elimination of Tuberculosis, the National Commission on Correctional Health Care, and the American Correctional Association. MMWR Recomm Rep 55 (RR-9): 144.
  22. Centers for Disease Control and Prevention, 2000. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 49 (RR-6): 151.
  23. Assistant Secretary of Defense for Health Affairs, 2012. Guideline for Tuberculosis Screening and Testing. Washington, DC: Department of Defense.
  24. United States Army Medical Command, 2013. MEDCOM Regulation 40-64: The Tuberculosis Surveillance and Control Program. Department of the Army. Joint Base San Antonio, Fort Sam Houston, TX. Available at: http://www.pdhealth.mil/tuberculosis.asp. Accessed September 8, 2015.
  25. Centers for Disease Control and Prevention, 2012. Mantoux Tuberculin Skin Testing Products. Available at: http://www.cdc.gov/TB/education/Mantoux/default.htm. Accessed October 18, 2014.
  26. Jensen PA, Lambert LA, Iademarco MF, Ridzon R, , 2005. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 54 (RR-17): 1141.
  27. Division of Tuberculosis Elimination, 2013. Core Curriculum on Tuberculosis, 6th edition. Atlanta, GA: Centers for Disease Control and Prevention.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.15-0539
Loading
/content/journals/10.4269/ajtmh.15-0539
Loading

Data & Media loading...

  • Received : 23 Jul 2015
  • Accepted : 10 Aug 2015

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error